SCHEMBL741893

SCHEMBL741893

CN(C)CCOc1ccc(C(=O)Nc2n[nH]c3sc(C(=O)NC(C)(C)c4ccccc4F)cc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.44
KIT P10721 6/20 0.43
FLT3 P36888 6/20 0.42
HDAC1 Q13547 2/20 0.39
CACNA1H O95180 2/20 0.39
STK25 O00506 1/20 0.39
AURKA O14965 1/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
FGFR1 P11362 1/20 0.37
FGFR2 P21802 1/20 0.37
CACNA1B Q00975 1/20 0.36
DYRK3 O43781 1/20 0.36
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
CLK2 P49760 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740260 0.90 AURKA (0.47) IMPDH2KITFLT3HDAC1CACNA1H
SCHEMBL4633211 0.83 KIT (0.48) KITFLT3HDAC1CACNA1HSTK25
SCHEMBL741121 0.80 KIT (0.50) KITFLT3AURKAABL1BCR
SCHEMBL742867 0.79 ABL1 (0.58) KITFLT3HDAC1AURKAKDM4E
SCHEMBL742153 0.79 ABL1 (0.60) KITFLT3HDAC1AURKAKDM4E
SCHEMBL739473 0.79 ABL1 (0.61) KITFLT3HDAC1AURKAKDM4E
SCHEMBL741946 0.79 ABL1 (0.61) KITFLT3HDAC1AURKAKDM4E
SCHEMBL741622 0.78 RAB9A (0.41) FLT3AURKAKDM4EPOLBABL1
SCHEMBL742121 0.78 AURKA (0.62) KITFLT3AURKAABL1BCR
SCHEMBL742527 0.78 AURKA (0.52) KITFLT3AURKAABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed